Skip to main content

Table 2 Baseline Characteristics of Cohort

From: Assessment of transition readiness in adolescents and young adults with chronic health conditions

 

Overall (N = 89)

Transitioned (N = 39)

Non-transitioned (N = 44)

P-value

Age, mean (SD), year

18.3 (1.6)

18.8 (1.6)

18.0 (1.5)

0.03

Gender, No., %

   

0.54

 Female

59 (66%)

14 (36%)

13 (30%)

 

 Male

30 (34%)

25 (64%)

31 (70%)

 

Ethnicity, No., %

   

0.59

 White

72 (81%)

31 (79%)

37 (84%)

 

 Non-white

17 (19%)

8 (21%)

7 (16%)

 

Household income, No., %

   

0.43

 < $25,000

11 (13%)

4 (10%)

7 (16%)

 

 $25,000–$45,999

16 (18%)

5 (13%)

9 (21%)

 

 $50,000–$74,999

13 (15%)

5 (13%)

8 (19%)

 

 $75,000–$99,999

6 (7%)

2 (5%)

4 (9%)

 

 $100,000–$150,000

8 (9%)

4 (10%)

4 (9%)

 

  > $150,000

7 (8%)

4 (10%)

1 (2%)

 

 Unknown

27 (31%)

15 (38%)

10 (23%)

 

Type of insurance, No., %

   

0.44

 Public

22 (26%)

8 (22%)

12 (29%)

 

 Private

62 (74%)

29 (78%)

29 (71%)

 

Specialty, No., %

   

0.16

 Rheumatology

50 (56%)

19 (49%)

28 (64%)

 

 Endocrinology

19 (21%)

8 (21%)

10 (23%)

 

 Gastroenterology

20 (23%)

12 (31%)

6 (14%)

 

TRAQ domain 1 score, mean (SD)

3.1 (1.0)

3.2 (1.0)

3.0 (0.8)

0.37

TRAQ domain 2 score, mean (SD)

3.7 (0.7)

3.9 (0.5)

3.7 (0.9)

0.21

Duration of disease, mean (SD), year

4.8 (3.9)

5.2 (3.9)

4.5 (4.0)

0.27

Have discussed transition with provider, No., %

35 (41%)

21 (54%)

13 (33%)

0.06

Have seen provider independently, No., %

   

0.22

 Always/Often/Sometimes

44 (51%)

23 (59%)

19 (45%)

 

 Never/Rarely

43 (49%)

16 (41%)

23 (55%)

 
  1. Abbreviations: TRAQ Transition Readiness Assessment Questionnaire